Old Web
English
Sign In
Acemap
>
Paper
>
THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
THU-141-Efficacy and safety of elbasvir/grazoprevir in a large real-life cohort of HCV-infected patients
2019
M. Gambato
A. Spinetti
L. Pasulo
R. D’Ambrosio
Massimo Puoti
M. Schiavini
Paolo Fabris
Paolo Sacchi
Roberto Gulminetti
Giada Carolo
Piergiorgio Scotton
Caterina Pozzan
M. Vinci
M. Viganò
S. Lobello
M. Zuin
Alessio Aghemo
Maria Grazia Rumi
Maurizio Carrara
Vinicio Manfrin
Caterina Uberti-Foppa
Sandro Panese
Francesca Cattelan
V. Paon
Angelo Pan
Ombretta Spinelli
Antonella dArminio Monforte
Agostino Colli
G. Spinzi
F.P. Russo
Liliana Chemello
Valter Vincenzi
Paolo Grossi
Elisabetta Buscarini
Giovanna Cardaci
Alessandro Soria
Barbara Menzaghi
Monia Mendeni
Elisabetta Degasperi
R. Soffredini
Maria Colpani
Laura Comi
Valentina Zuccaro
S. Zaltron
A. Gori
Paolo Del Poggio
A. Giorgini
Andrea Capretti
Massimo Memoli
Marie Graciella Pigozzi
Maria Cristina Rossi
Luisa Cavalletto
Franco Capra
Alberto Colombo
Clara Dibenedetto
Simona Landonio
Franco Noventa
P. Lampertico
Francesco Castelli
Alfredo Alberti
Stefano Fagiuoli
Keywords:
Virology
Cohort
Elbasvir, Grazoprevir
Internal medicine
Diabetes mellitus
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]